University of Miami The Aging Brain Navigating Cognition, Mental Health and Psychopharmacological Treatment 2025

• Target Audience: psychiatrists, geriatricians, and primary care physicians
• Sample video: contact me for sample video
• Information:

1. Overview

Course Date: 2025

2. Learning Objectives

Differentiate between cognitive changes associated with normal aging and common neurodegenerative disorders.

Apply evidence-based pharmacological strategies for Alzheimer’s disease, including symptomatic management and disease modification.

Implement non-pharmacological interventions for dementia and manage agitation and aggression effectively.

Identify “red flag” drugs and apply best practices in geriatric pharmacology to minimize adverse outcomes.

Evaluate and treat depression, anxiety, and family dynamic issues within the context of geriatric psychiatry.

3. Target Audience

Best for psychiatrists, geriatricians, and primary care physicians who want updates on dementia care, geriatric pharmacology, and cognitive assessment.

4. Topics

Pharmacological Agents for Alzheimer’s Disease, Part 1 – Symptomatic Management

Pharmacological Agents for Alzheimer’s Disease, Part 2 – Disease Modification

Non Pharmacological Management of Alzheimer’s and Related Dementias

Pharmacological Management of Agitation & Aggression in Alzheimer’s and Related Dementias

Overview of Common Neurodegenerative Disorders in Older Adults

Cognitive Changes That Occur in Normal Aging

Geriatric Pharmacology – Red Flag Drugs & Best Practices

Geriatric Pharmacology – Depression & Anxiety

Treating the Family Constellation in Geriatric Psychiatry and Dementia

New Breakthroughs in Cognitive Neuropsychological Assessment

Improving Cognition in Older People